[Initial controlled clinical trials of an oral anticholera vaccine during the cholera epidemic in the district of Malemba-Nkulu (Shaba-Zaire)].
The authors have utilized the Institut Pasteur anticholeric vaccine by oral passage amid the Malemba - Nkulu area population. The choleric epidemic beginning six months after the vaccine oral passage. The results had been 67 cholera case on 18,377 subjects non inoculated 25 case on 6,249 subjects inoculated by inject vaccine, 3 case on 12,014 subjects inoculated by vaccine oral passage.
D000284:Administration, Oral; D002771:Cholera / Q000453:epidemiology / Q000517:prevention & control; D022121:Cholera Vaccines / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D015023:Democratic Republic of the Congo; D006801:Humans
D022121:Cholera Vaccines
Premiers essais controlés du vaccin anticholérique oral au cours de l'épidémie de choléra dans la zone de Malemba-Nkulu (Shaba-Zäire).